Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma

L. Chiecchio, R. K M Protheroe, A. H. Ibrahim, K. L. Cheung, C. Rudduck, G. P. Dagrada, E. D. Cabanas, T. Parker, M. Nightingale, A. Wechalekar, K. H. Orchard, C. J. Harrison, N. C P Cross, G. J. Morgan, F. M. Ross

Research output: Contribution to journalArticle

Abstract

In myeloma, the prognostic impact of different strategies used to detect chromosome 13 deletion (Δ13) remains controversial. To address this, we compared conventional cytogenetics and interphase fluorescence in situ hybridization (iFISH) in a large multicenter study (n=794). The ability to obtain abnormal metaphases was associated with a poor prognosis, which was worse if Δ13, p53 deletion or t(4;14) was present, but only Δ13 remained significant on multivariate analysis. Patients with Δ13, by either cytogenetics or iFISH, had a poor prognosis. However, when cases with Δ13 detectable by both cytogenetics and iFISH were separated from those detected by iFISH only, the poor prognosis of iFISH-detectable Δ13 disappeared; their outcome matched that of patients with no detectable Δ13 (P=0.115). Addition of ploidy status to iFISH-Δ13 did not affect the prognostic value of the test. Indeed both cytogenetics and iFISH Δ13 divided both hyperdiploidy and nonhyperdiploidy into two groups with similar prognoses, indicating that the poor prognosis of ploidy is entirely due to its association with Δ13. We conclude that Δ13 detected by metaphase analysis is a critical prognostic factor in myeloma. Absence of Δ13, even in those patients yielding only normal or no metaphases, is associated with a relatively good prognosis.

Original languageEnglish
Pages (from-to)1610-1617
Number of pages8
JournalLeukemia
Volume20
Issue number9
DOIs
Publication statusPublished - Sep 2006

Fingerprint

Chromosomes, Human, Pair 13
Interphase
Fluorescence In Situ Hybridization
Cytogenetics
Metaphase
Ploidies
Chromosome Deletion
Polyploidy
Multicenter Studies
Multivariate Analysis

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Chiecchio, L., Protheroe, R. K. M., Ibrahim, A. H., Cheung, K. L., Rudduck, C., Dagrada, G. P., ... Ross, F. M. (2006). Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia, 20(9), 1610-1617. https://doi.org/10.1038/sj.leu.2404304

Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. / Chiecchio, L.; Protheroe, R. K M; Ibrahim, A. H.; Cheung, K. L.; Rudduck, C.; Dagrada, G. P.; Cabanas, E. D.; Parker, T.; Nightingale, M.; Wechalekar, A.; Orchard, K. H.; Harrison, C. J.; Cross, N. C P; Morgan, G. J.; Ross, F. M.

In: Leukemia, Vol. 20, No. 9, 09.2006, p. 1610-1617.

Research output: Contribution to journalArticle

Chiecchio, L, Protheroe, RKM, Ibrahim, AH, Cheung, KL, Rudduck, C, Dagrada, GP, Cabanas, ED, Parker, T, Nightingale, M, Wechalekar, A, Orchard, KH, Harrison, CJ, Cross, NCP, Morgan, GJ & Ross, FM 2006, 'Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma', Leukemia, vol. 20, no. 9, pp. 1610-1617. https://doi.org/10.1038/sj.leu.2404304
Chiecchio L, Protheroe RKM, Ibrahim AH, Cheung KL, Rudduck C, Dagrada GP et al. Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia. 2006 Sep;20(9):1610-1617. https://doi.org/10.1038/sj.leu.2404304
Chiecchio, L. ; Protheroe, R. K M ; Ibrahim, A. H. ; Cheung, K. L. ; Rudduck, C. ; Dagrada, G. P. ; Cabanas, E. D. ; Parker, T. ; Nightingale, M. ; Wechalekar, A. ; Orchard, K. H. ; Harrison, C. J. ; Cross, N. C P ; Morgan, G. J. ; Ross, F. M. / Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. In: Leukemia. 2006 ; Vol. 20, No. 9. pp. 1610-1617.
@article{4b994df8ad3b48d592c86921dc804b13,
title = "Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma",
abstract = "In myeloma, the prognostic impact of different strategies used to detect chromosome 13 deletion (Δ13) remains controversial. To address this, we compared conventional cytogenetics and interphase fluorescence in situ hybridization (iFISH) in a large multicenter study (n=794). The ability to obtain abnormal metaphases was associated with a poor prognosis, which was worse if Δ13, p53 deletion or t(4;14) was present, but only Δ13 remained significant on multivariate analysis. Patients with Δ13, by either cytogenetics or iFISH, had a poor prognosis. However, when cases with Δ13 detectable by both cytogenetics and iFISH were separated from those detected by iFISH only, the poor prognosis of iFISH-detectable Δ13 disappeared; their outcome matched that of patients with no detectable Δ13 (P=0.115). Addition of ploidy status to iFISH-Δ13 did not affect the prognostic value of the test. Indeed both cytogenetics and iFISH Δ13 divided both hyperdiploidy and nonhyperdiploidy into two groups with similar prognoses, indicating that the poor prognosis of ploidy is entirely due to its association with Δ13. We conclude that Δ13 detected by metaphase analysis is a critical prognostic factor in myeloma. Absence of Δ13, even in those patients yielding only normal or no metaphases, is associated with a relatively good prognosis.",
author = "L. Chiecchio and Protheroe, {R. K M} and Ibrahim, {A. H.} and Cheung, {K. L.} and C. Rudduck and Dagrada, {G. P.} and Cabanas, {E. D.} and T. Parker and M. Nightingale and A. Wechalekar and Orchard, {K. H.} and Harrison, {C. J.} and Cross, {N. C P} and Morgan, {G. J.} and Ross, {F. M.}",
year = "2006",
month = "9",
doi = "10.1038/sj.leu.2404304",
language = "English",
volume = "20",
pages = "1610--1617",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma

AU - Chiecchio, L.

AU - Protheroe, R. K M

AU - Ibrahim, A. H.

AU - Cheung, K. L.

AU - Rudduck, C.

AU - Dagrada, G. P.

AU - Cabanas, E. D.

AU - Parker, T.

AU - Nightingale, M.

AU - Wechalekar, A.

AU - Orchard, K. H.

AU - Harrison, C. J.

AU - Cross, N. C P

AU - Morgan, G. J.

AU - Ross, F. M.

PY - 2006/9

Y1 - 2006/9

N2 - In myeloma, the prognostic impact of different strategies used to detect chromosome 13 deletion (Δ13) remains controversial. To address this, we compared conventional cytogenetics and interphase fluorescence in situ hybridization (iFISH) in a large multicenter study (n=794). The ability to obtain abnormal metaphases was associated with a poor prognosis, which was worse if Δ13, p53 deletion or t(4;14) was present, but only Δ13 remained significant on multivariate analysis. Patients with Δ13, by either cytogenetics or iFISH, had a poor prognosis. However, when cases with Δ13 detectable by both cytogenetics and iFISH were separated from those detected by iFISH only, the poor prognosis of iFISH-detectable Δ13 disappeared; their outcome matched that of patients with no detectable Δ13 (P=0.115). Addition of ploidy status to iFISH-Δ13 did not affect the prognostic value of the test. Indeed both cytogenetics and iFISH Δ13 divided both hyperdiploidy and nonhyperdiploidy into two groups with similar prognoses, indicating that the poor prognosis of ploidy is entirely due to its association with Δ13. We conclude that Δ13 detected by metaphase analysis is a critical prognostic factor in myeloma. Absence of Δ13, even in those patients yielding only normal or no metaphases, is associated with a relatively good prognosis.

AB - In myeloma, the prognostic impact of different strategies used to detect chromosome 13 deletion (Δ13) remains controversial. To address this, we compared conventional cytogenetics and interphase fluorescence in situ hybridization (iFISH) in a large multicenter study (n=794). The ability to obtain abnormal metaphases was associated with a poor prognosis, which was worse if Δ13, p53 deletion or t(4;14) was present, but only Δ13 remained significant on multivariate analysis. Patients with Δ13, by either cytogenetics or iFISH, had a poor prognosis. However, when cases with Δ13 detectable by both cytogenetics and iFISH were separated from those detected by iFISH only, the poor prognosis of iFISH-detectable Δ13 disappeared; their outcome matched that of patients with no detectable Δ13 (P=0.115). Addition of ploidy status to iFISH-Δ13 did not affect the prognostic value of the test. Indeed both cytogenetics and iFISH Δ13 divided both hyperdiploidy and nonhyperdiploidy into two groups with similar prognoses, indicating that the poor prognosis of ploidy is entirely due to its association with Δ13. We conclude that Δ13 detected by metaphase analysis is a critical prognostic factor in myeloma. Absence of Δ13, even in those patients yielding only normal or no metaphases, is associated with a relatively good prognosis.

UR - http://www.scopus.com/inward/record.url?scp=33747611919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747611919&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404304

DO - 10.1038/sj.leu.2404304

M3 - Article

C2 - 16826223

AN - SCOPUS:33747611919

VL - 20

SP - 1610

EP - 1617

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 9

ER -